Roche Xenical Glycemic Control Not Independent Of Weight Loss – EU Label
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
European labeling for Roche’s Xenical for type 2 diabetes does not support a reduction in hemoglobin A1c levels that is distinct from weight loss.